183 related articles for article (PubMed ID: 12064015)
1. Tenofovir disoproxil fumarate (Viread).
Porche DJ
J Assoc Nurses AIDS Care; 2002; 13(3):100-2. PubMed ID: 12064015
[TBL] [Abstract][Full Text] [Related]
2. Tenacious tenofovir struts its stuff in a virtual ICAAC.
Huff B
GMHC Treat Issues; 2001 Oct; 15(10):9-11. PubMed ID: 11727571
[No Abstract] [Full Text] [Related]
3. Tenofovir disoproxil fumarate.
Chapman T; McGavin J; Noble S
Drugs; 2003; 63(15):1597-608. PubMed ID: 12887265
[TBL] [Abstract][Full Text] [Related]
4. Tenofovir disoproxil fumarate: a nucleotide reverse transcriptase inhibitor for the treatment of HIV infection.
Fung HB; Stone EA; Piacenti FJ
Clin Ther; 2002 Oct; 24(10):1515-48. PubMed ID: 12462284
[TBL] [Abstract][Full Text] [Related]
5. New uses for tenofovir: more questions about d4T.
Proj Inf Perspect; 2003 Jan; (35):15-6. PubMed ID: 12647676
[TBL] [Abstract][Full Text] [Related]
6. Tenofovir disoproxil fumarate.
Antoniou T
Drugs; 2003; 63(15):1609-10. PubMed ID: 12887266
[No Abstract] [Full Text] [Related]
7. [Tenofovir (Viread)].
Sidahora; 2002; (1):20-1. PubMed ID: 12772661
[No Abstract] [Full Text] [Related]
8. Atazanavir (Reyataz): new recommendations if combined with tenofovir (Viread) -- and warning on Viagra, Cialis, and Levitra.
AIDS Treat News; 2004 Mar; (399):5. PubMed ID: 15199867
[TBL] [Abstract][Full Text] [Related]
9. Failure of combination abacavir + tenofovir + lamivudine (3TC).
AIDS Treat News; 2003 Jul; (393):2. PubMed ID: 14679923
[TBL] [Abstract][Full Text] [Related]
10. Meeting notes from the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. Exploring once-daily tenofovir + 3TC + abacavir: an argument for clinical-trials-based data.
Becker S; Feinberg J
AIDS Clin Care; 2003 Sep; 15(9):81. PubMed ID: 14669727
[TBL] [Abstract][Full Text] [Related]
11. Kidney damage reported in some tenofovir users.
TreatmentUpdate; 2003; 15(2):6-7. PubMed ID: 12693362
[No Abstract] [Full Text] [Related]
12. Tenofovir disoproxil fumarate for the treatment of HIV infection.
Pham PA; Gallant JE
Expert Opin Drug Metab Toxicol; 2006 Jun; 2(3):459-69. PubMed ID: 16863446
[TBL] [Abstract][Full Text] [Related]
13. Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1.
Breton G; Alexandre M; Duval X; Prie D; Peytavin G; Leport C; Vildei JL
Scand J Infect Dis; 2004; 36(6-7):527-8. PubMed ID: 15307594
[TBL] [Abstract][Full Text] [Related]
14. Tenofovir drug interactions: ddI and d4T.
TreatmentUpdate; 2003; 15(2):7. PubMed ID: 12693363
[No Abstract] [Full Text] [Related]
15. Renal safety of tenofovir in HIV treatment-experienced patients.
Izzedine H; Isnard-Bagnis C; Hulot JS; Vittecoq D; Cheng A; Jais CK; Launay-Vacher V; Deray G
AIDS; 2004 Apr; 18(7):1074-6. PubMed ID: 15096814
[TBL] [Abstract][Full Text] [Related]
16. Tenofovir: FDA hearing on important new antiretroviral.
James JS
AIDS Treat News; 2001 Oct; (372):2-4. PubMed ID: 11702411
[No Abstract] [Full Text] [Related]
17. French investigators warn of LPV/TDF/ddI interaction.
Carter M
IAPAC Mon; 2003 Dec; 9(12):315. PubMed ID: 15055164
[No Abstract] [Full Text] [Related]
18. Tenofovir disoproxil fumarate.
Kumar A
Drugs; 2003; 63(15):1609-10. PubMed ID: 12887267
[No Abstract] [Full Text] [Related]
19. Tenofovir disoproxil fumarate: clinical pharmacology and pharmacokinetics.
Kearney BP; Flaherty JF; Shah J
Clin Pharmacokinet; 2004; 43(9):595-612. PubMed ID: 15217303
[TBL] [Abstract][Full Text] [Related]
20. The use of tenofovir disoproxil fumarate for the treatment of nucleoside-resistant HIV-1.
McColl DJ; Miller MD
J Antimicrob Chemother; 2003 Feb; 51(2):219-23. PubMed ID: 12562684
[No Abstract] [Full Text] [Related]
[Next] [New Search]
